5337-03-1

Basic information

• Product Name: Tetrahydro-2H-pyran-4-carboxylic acid
• Synonyms: CHEMBRDG-BB 4004296;ASINEX-REAG BAS 06502515;TETRAHYDRO-2H-PYRAN-4-CARBOXYLIC ACID;TETRAHYDRO-PYRAN-4-CARBOXYLIC ACID;TETRAHYDRO-2H-PYRAN-4-YL-CARBOXYLIC ACID;Tetrahydro-2H-pyrane-4-carboxylicacid;Terahydropyran-4-yl-carboxylic acid;Tetrahydro-2H-pyran-4-carboxylic acid 98%
• CAS NO: 5337-03-1
• Molecular Formula: C₆H₁₀O₃
• Molecular Weight: 130.14
• EINECS: 1592732-453-0
• Product Categories: blocks;Carboxes;Heterocycles;Carboxylic Acids;Pyrans, Piperidines &Piperazines;Building Blocks;Pyran;Carboxylic Acids;Pyrans, Piperidines & Piperazines;organic intermediate
• Mol File: 5337-03-1.mol
• Article Data: 36

Chemical Properties

• Melting Point: 87 °C
• Boiling Point: 114-146°C 11mm
• Flash Point: 114 °C
• Appearance: White to off-white/Solid
• Density: 1.1066 (rough estimate)
• Vapor Pressure: 0.00282mmHg at 25°C
• Refractive Index: 1.4315 (estimate)
• Storage Temp.: Sealed in dry,Room Temperature
• Solubility: soluble in Methanol
• PKA: 4.43±0.20(Predicted)
• CAS DataBase Reference: Tetrahydro-2H-pyran-4-carboxylic acid(CAS DataBase Reference)
• NIST Chemistry Reference: Tetrahydro-2H-pyran-4-carboxylic acid(5337-03-1)
• EPA Substance Registry System: Tetrahydro-2H-pyran-4-carboxylic acid(5337-03-1)

Safety Data

• Hazard Codes: Xi,Xn
• Statements: 36/37/38-41-37/38-22-20/21/22
• Safety Statements: 26-36/37/39-22-39-24/25
• RIDADR: 2811
• HazardClass: IRRITANT
• Hazardous Substances Data: 5337-03-1(Hazardous Substances Data)

Usage

Chemical Properties

white to light yellow crystal powder

InChI:InChI=1/C6H10O3/c7-6(8)5-1-3-9-4-2-5/h5H,1-4H2,(H,7,8)/p-1

Upstream product

• 110238-91-0 tetrahydropyran-4-carboxylic acid methyl ester 
• 14774-37-9 (tetrahydro-2H-pyran-4-yl)methanol 
• 4295-99-2 tetrahydro-2H-pyran-4-carbonitrile 
• 134419-59-3 4-oxanyl methanesulfonate 
• 25637-16-5 4-bromotetrahydro-2H-pyran 
• 97986-34-0 toluene-4-sulfonic acid tetrahydropyran-4-yl ester 
• 848821-06-7 4-cyanotetrahydro-2H-pyran-4-carboxylic acid 
• 362703-30-8 methyl 4-cyanotetrahydro-2H-pyran-4-carboxylate 
• 149777-00-4 4,4-dimethyl dihydro-2H-pyran-4,4(3H)-dicarboxylate 
• 5382-77-4 tetrahydro-pyran-4,4-dicarboxylic acid diethyl ester 
• 29943-42-8 Tetrahydro-4H-pyran-4-one 
• 50675-18-8 3,4,5,6-tetrahydro-2H-pyran-4-carbaldehyde 
• 101765-10-0 tetrahydro-4-(methoxymethylene)-2H-pyran 
• 111-44-4 3-oxa-1,5-dichloropentane 

Downstream Products

• 96835-17-5 ethyl tetrahydro-2H-pyran-4-carboxylate 
• 38041-19-9 4-aminotetrahydropyran 
• 14774-37-9 (tetrahydro-2H-pyran-4-yl)methanol 
• 40191-32-0 tetrahydro-2H-pyran-4-carbonylchloride 
• 53035-92-0 4-isocyanatotetrahydro-2H-pyran 
• 182314-96-1 4,6-dichloro-3-[2-(4-{[3-(tetrahydro-pyran-4-yl)-ureido]-methyl}-phenylcarbamoyl)-vinyl]-1H-indole-2-carboxylic acid ethyl ester 
• 917566-84-8 phenyl tetrahydropyran-4-carboxylate 
• 1118605-21-2 C₂₆H₄₀N₂O₂ 
• 917806-77-0 C₂₇H₄₁N₅O₂ 
• 778642-54-9 4-{4-[(phenylmethyl)oxy]phenyl}-1-(tetrahydro-2H-pyran-4-ylcarbonyl)-1,2,3,6-tetrahydropyridine 
• 790223-74-4 4-(tetrahydro-pyran-4-carbonyl)-piperazine-1-carboxylic acid benzyl ester 
• 872991-70-3 N-[3-fluoro-4-(4-morpholinyl)phenyl]tetrahydro-2H-pyran-4-carboxamide 
• 1207511-62-3 1-{[(3S,4R)-1-tert-butyl-4-(2,4-difluorophenyl)pyrrolidin-3-yl]carbonyl}-5S-(4-chlorophenyl)-4-(tetrahydro-2H-pyran-4-ylcarbonyl)-1,4-diazocane 

Relevant articles and documents

Oxidation of Primary Alcohols and Aldehydes to Carboxylic Acids via Hydrogen Atom Transfer

The oxidation of primary alcohols and aldehydes to the corresponding carboxylic acids is a fundamental reaction in organic synthesis. In this paper, we report a new chemoselective process for the oxidation of primary alcohols and aldehydes. This metal-free reaction features a new oxidant, an easy to handle procedure, high isolated yields, and good to excellent functional group tolerance even in the presence of vulnerable secondary alcohols and tert-butanesulfinamides.

SUBSTITUTED AZASPIRO(4.5)DECANE DERIVATIVES

The invention relates to substituted spirocyclic cyclohexane derivatives which have an affinity for the μ opioid receptor and/or the ORL1 receptor, processes for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

Compounds with cardiac myosin activating function and pharmaceutical composition containing the same for treating or preventing heart failure

Disclosed are a compound having cardiotonic activity and a pharmaceutical composition containing the same, and the composition containing the compound, according to the present invention, is useful for preventing and treating heart failure.COPYRIGHT KIPO 2016